Summary
Machine-generated summaryThe contract concerns the supply of the medicinal product burosumab 20 mg injection solution and burosumab 30 mg injection solution with the active substance burosumab, known as Crysvita. The product is intended for paediatric patients with the X-linked form of hypophosphataemic rickets, provided that all of the following criteria are met: documented high serum FGF-23 concentration, genetically confirmed PHEX gene mutation, persistent low hypophosphataemia despite long-term substitution with maximally tolerated doses of phosphate solution and active vitamin D, and progression of bone deformities despite maximally tolerated doses of standard therapy with phosphates and vitamin D.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 6 hours ago
More from this buyer
Full buyer profile2 open tenders right now
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| ELMED, s.r.o. | 1 | €3.4M | Mar 2026 |
| PHOENIX Zdravotnícke zásobovanie, a.s. | 1 | n/a | Sep 2026 |
Based on 2 awards with a linked company profile over the last 5 years.
Similar tenders
1
day left
€678,021
est. value
2
days left
€1,621,103
est. value
2
days left
Operating theatre instruments - Instruments and accessories for the Da Vinci robotic telemanipulator
€812,659
est. value
5
days left
€352,332
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,021,720
- Buyer track record on Aperlena
- 8 notices tracked · 3 awarded
- €3,385,599 in awarded contracts
Never miss a tender like this
31 new notices in Medical equipment & pharmaceuticals in Slovakia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert